Wust P, Stahl H, Löffel J, Seebass M, Riess H, Felix R
Strahlenklinik und Poliklinik, Universitätsklinikum Rudolf Virchow, Freie Universität Berlin, Germany.
Int J Hyperthermia. 1995 Mar-Apr;11(2):151-67. doi: 10.3109/02656739509022453.
Temperature/time curves and corresponding CT scans of > 200 regional heat treatments with the hyperthermia system BSD-2000 in 43 patients have been analysed. In vivo variables and treatment parameters such as local specific absorption rate SAR, local relative SAR parallel SAR parallel, total power P, local cooling coefficients wb, and local steady-state temperature elevations delta Tss (above systemic temperature) have been determined. For determination of wb the well-known and accepted steady-state approach has been used, which was slightly modified for the purposes of this study. Specifically, comparison of cooling coefficients at the beginning and end of heat treatments were performed in tumours and normal tissues. Other variables are anatomical descriptors from CT scans, score of side effects plim, and various clinical factors. A variance analysis of the dependent variables, specifically delta Tss and parallel SAR parallel, is performed with respect to factors which were estimated as predictive. The intratumoral steady-state temperature elevations are determined by the perfusion-related cooling coefficients and local SAR to almost the same extent. Increase of cooling coefficients in tumours during the heat treatment characterizing the thermoregulatory potential have a slight but less important influence with respect to the achieved temperature elevations. SAR is influenced by several anatomical factors which determine the relative SAR distribution and clinical factors which limit the total power P. However, options for controlling present RHT systems in order to optimize the relative SAR distribution or to avoid hot spot phenomena appear limited. Three-dimensional modelling calculations show that the spatial arrangement of electrical interfaces emerging from bone and fat structures limits SAR control in available RHT technology and is mainly responsible for local power-dependent discomfort (Wust et al. 1994b). Some conclusions are drawn, about how technological development of hyperthermia technology can contribute towards overcoming this problem.
分析了43例患者使用BSD - 2000热疗系统进行的200多次局部热疗的温度/时间曲线及相应的CT扫描结果。已确定了体内变量和治疗参数,如局部比吸收率(SAR)、局部相对SAR(平行SAR平行)、总功率(P)、局部冷却系数(wb)以及局部稳态温度升高(δTss,高于全身温度)。为了确定wb,采用了广为人知且被认可的稳态方法,并针对本研究的目的进行了轻微修改。具体而言,在肿瘤和正常组织中对热疗开始和结束时的冷却系数进行了比较。其他变量包括CT扫描的解剖学描述符、副作用评分(plim)以及各种临床因素。针对被估计为具有预测性的因素,对因变量,特别是δTss和平行SAR平行进行了方差分析。肿瘤内的稳态温度升高在几乎相同程度上由与灌注相关的冷却系数和局部SAR决定。热疗期间肿瘤冷却系数的增加表征了体温调节潜力,对实现的温度升高有轻微但不太重要的影响。SAR受几个决定相对SAR分布的解剖学因素以及限制总功率P的临床因素影响。然而,控制现有区域热疗系统以优化相对SAR分布或避免热点现象的选择似乎有限。三维建模计算表明,从骨骼和脂肪结构出现的电接口的空间排列限制了现有区域热疗技术中的SAR控制,并且主要导致局部功率相关的不适(Wust等人,1994b)。得出了一些关于热疗技术的技术发展如何有助于克服这一问题的结论。